pharmaceutical investing Hemispherx Announces First Participant Received Initial Dosing in Breast Cancer Clinical Trial
pharmaceutical investing 3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma
Merus Announces Recent Corporate Developments and Financial Results for the Fourth Quarter and Full Year 2017
BeiGene Presents Clinical Data on Pamiparib in Chinese Patients with Ovarian Cancers or Triple-Negative Breast Cancer
3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin’s Lymphoma
Kobo Resources Intersects 21.5 m at 1.14 g/t Au and 20.0 m at 1.41 g/t Au at the Jagger Zone and Files FY 2025 Financial Results
Freegold Achieves over 90% Gold Recovery Using BIOX® and greater than 92% Gold Recovery using POX - Additional Metallurgical Work Remains Ongoing
Silver Crown Royalties Executes LOI with Kuya Silver for a Silver Royalty on the Bethania Silver Project
